BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30924571)

  • 1. Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T.
    Krikken E; van der Kemp WJM; van Diest PJ; van Dalen T; van Laarhoven HWM; Luijten PR; Klomp DWJ; Wijnen JP
    NMR Biomed; 2019 Jun; 32(6):e4086. PubMed ID: 30924571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of alterations in membrane metabolism during neoadjuvant chemotherapy in patients with breast cancer using phosphorus magnetic resonance spectroscopy at 7 Tesla.
    van der Kemp WJ; Stehouwer BL; Luijten PR; van den Bosch MA; Klomp DW
    Springerplus; 2014; 3():634. PubMed ID: 25932360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.
    Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; Davidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ
    Gut; 1998 May; 42(5):735-43. PubMed ID: 9659173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profile of liver damage in non-cirrhotic virus C and autoimmune hepatitis: A proton decoupled
    Hakkarainen A; Puustinen L; Kivisaari R; Boyd S; Nieminen U; Arkkila P; Lundbom N
    Eur J Radiol; 2017 May; 90():205-211. PubMed ID: 28583636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment.
    Leach MO; Verrill M; Glaholm J; Smith TA; Collins DJ; Payne GS; Sharp JC; Ronen SM; McCready VR; Powles TJ; Smith IE
    NMR Biomed; 1998 Nov; 11(7):314-40. PubMed ID: 9859939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
    Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
    J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro.
    Thomas CP; Dixon RM; Tian M; Butler SA; Counsell CJ; Bradley JK; Adams GE; Radda GK
    Br J Cancer; 1994 Apr; 69(4):633-40. PubMed ID: 8142251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorus magnetic resonance spectroscopy in malformations of cortical development.
    Andrade CS; Otaduy MC; Valente KD; Maia DF; Park EJ; Valério RM; Tsunemi MH; Leite CC
    Epilepsia; 2011 Dec; 52(12):2276-84. PubMed ID: 21973076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiabatic multi-echo ³¹P spectroscopic imaging (AMESING) at 7 T for the measurement of transverse relaxation times and regaining of sensitivity in tissues with short T₂ values.
    van der Kemp WJ; Boer VO; Luijten PR; Stehouwer BL; Veldhuis WB; Klomp DW
    NMR Biomed; 2013 Oct; 26(10):1299-307. PubMed ID: 23553945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T.
    Agarwal N; Sung YH; Jensen JE; daCunha G; Harper D; Olson D; Renshaw PF
    Bipolar Disord; 2010 Dec; 12(8):825-33. PubMed ID: 21176029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
    Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
    Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo Metabolic Profiles as Determined by
    Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
    Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H/31P polarization transfer at 9.4 Tesla for improved specificity of detecting phosphomonoesters and phosphodiesters in breast tumor models.
    Wijnen JP; Jiang L; Greenwood TR; van der Kemp WJ; Klomp DW; Glunde K
    PLoS One; 2014; 9(7):e102256. PubMed ID: 25036036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.
    Esmaeili M; Moestue SA; Hamans BC; Veltien A; Kristian A; Engebråten O; Maelandsmo GM; Gribbestad IS; Bathen TF; Heerschap A
    J Magn Reson Imaging; 2015 Mar; 41(3):601-9. PubMed ID: 24532410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy.
    Richardson AJ; Cox IJ; Sargentoni J; Puri BK
    NMR Biomed; 1997 Oct; 10(7):309-14. PubMed ID: 9471121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
    Jeon MJ; Lee Y; Ahn S; Lee C; Kim OH; Oh BC; Yu U; Kim H
    Acta Radiol; 2015 Sep; 56(9):1051-60. PubMed ID: 25270373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy.
    Schlemmer HP; Sawatzki T; Sammet S; Dornacher I; Bachert P; van Kaick G; Waldherr R; Seitz HK
    J Hepatol; 2005 May; 42(5):752-9. PubMed ID: 15826726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.